PELICAN THERAPEUTICS INC has a total of 21 patent applications. It decreased the IP activity by 63.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are CYTUNE, GILLIES STEPHEN D and TECHNOPHARM.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Russian Federation | 1 | |
#12 | Singapore | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Schreiber Taylor H | 16 |
#2 | Hutchins Jeff T | 13 |
#3 | Taylor H Schreiber | 2 |
#4 | Jeff T Hutchins | 2 |
#5 | Marfil-Garza Braulio | 1 |
#6 | Seavey Matthew | 1 |
#7 | Jasuja Rahul | 1 |
#8 | Jasuja Rahul R | 1 |
#9 | Shapiro A M | 1 |
#10 | Hutchins Jeff | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021062371A1 | Tnfrsf25-mediated treatments of immune diseases and disorders | |
WO2021041672A1 | Methods of treating cancer using tnfrsf25 antibodies | |
CN109219620A | Anti-TNF RSF25 antibody | |
WO2016081455A1 | Human tnfrsf25 antibody |